EMA reviews gene therapy for Haemophilia B
EMA (European Medicines Agency) has started reviewing the CSL Behring's MAA for gene therapy etranacogene dezaparvovec (EtranaDez), for the patients getting treatment for Haemophila B.
Clinical Trials | 28/04/2022 | By Sudeep Soparkar | 752
ALS drug by Biogen and Ionis Pharmaceuticals fails in trials
Biogen and Ionis Pharmaceuticals were hoping to be the first to find a cure for ALS. That dream has now fizzled out with the companies calling it quits after receiving disappointing results from a phase 1 clinical trial.
Clinical Trials | 27/04/2022 | By Sudeep Soparkar | 627
Anti-Tigit drug of Roche fails stage study
Roche's Genentech had disappointing news to share this week regarding its lung cancer hopeful.
Clinical Trials | 26/04/2022 | By Sudeep Soparkar | 731
Funds of $130m raised for B cell medications
Be Bio raises $130m to foster designed B cell medications. As a feature of the financing, ARCH Venture Partners overseeing chief Steven Gillis will join Be Bio's governing body.
Clinical Trials | 23/04/2022 | By Sudeep Soparkar | 631
BioXcel to develop drugs in oncology
BioXcel shapes entirely claimed auxiliary OnkosXcel to foster prescriptions centered in oncology
Clinical Trials | 21/04/2022 | By Sudeep Soparkar | 690
IDB therapies to improve with lymphoid cell maturity
New knowledge on lymphoid cell maturity could lead to more effective IBD therapies
Clinical Trials | 18/04/2022 | By Sudeep Soparkar | 600
Effects of rilzabrutinib in individuals with insusceptible thrombocytopenia
Positive phase 1/2 study results of rilzabrutinib in people with immune thrombocytopenia published in The New England Journal of Medicine
Clinical Trials | 16/04/2022 | By Sudeep Soparkar | 813
Cryo-electron microscopy answers for help underlying science research
Thermo Fisher Scientific, the world innovator in serving science, as of late sent the cutting edge cryo-transmission electron magnifying lens at the Center for Cellular and Molecular Biology (CCMB), Hyderabad, Telangana. The office was inaugurated by Dr Shekhar Mande, chief general, Council of Scientific and Industrial Research (CSIR).
Clinical Trials | 13/04/2022 | By Sudeep Soparkar | 604
New Toolkit Supports Digital Endpoints in Drug Development
DiMe, Biogen, Eli Lilly, Pfizer, and other top pharma companies launched a toolkit to ensure that organizations develop digital endpoint evidence in an acceptable way during drug development.
Clinical Trials | 12/04/2022 | By Sudeep Soparkar | 526
The GTAEC is an independent body of experts representing diverse areas of biomedical research, concerned government agencies and other stakeholders constituted and notified by the department of health research, Union ministry of health and family welfare to oversee the activities in the field of gene therapy research in India
Clinical Trials | 17/02/2022 | By Darshana | 638
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy